AEGIR — Aegirbio AB Income Statement
0.000.00%
Last trade - 00:00- SEK13.43m
- SEK24.33m
- SEK1.71m
Annual income statement for Aegirbio AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|
| Period Length: | 11 W | 10 W | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 0 | 0.014 | 13.3 | 1.71 |
| Cost of Revenue | ||||
| Gross Profit | — | — | 5.51 | -23.7 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Unusual Expense / Income | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | — | 18.5 | 95.8 | 367 |
| Operating Profit | 0 | -18.5 | -82.6 | -365 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -0 | -18.5 | -92.7 | -364 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -0 | -18.5 | -92.3 | -363 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -0 | -18.5 | -92.3 | -363 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -0 | -18.5 | -92.3 | -363 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0 | -1.42 | -5.54 | -9.53 |
| Dividends per Share |